How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

By Silvio E. Inzucchi, B. Zinman, D. Fitchett, C. Wanner, E. Ferrannini, Martin Schumacher, C. Schmoor, K. Ohneberg, O. Johansen, J. George and 3 more. Diabetes Care, 2017

631 citations recorded by the source corpus.